ArticleBriefings in bioinformatics2026
scHILL: deciphering individual-level immune cell heterogeneity with single-cell RNA sequencing data.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Deep learning frameworks have been developed for interpreting single-cell RNA sequencing (scRNA-seq) data and have demonstrated excellent performance across a range of tasks. However, existing methods remain limited in their ability to characterize heterogeneity at the individual level. To address this gap, we present scHILL, a framework that integrates a masked autoencoder (MAE) with a multilayer perceptron (MLP) to decipher phenotypic heterogeneity arises from immune cell heterogeneity among individuals under specific disease conditions. The MAE, pretrained with data augmentation, enables self-supervised feature learning without labels and effectively mitigates the challenge of limited sample size. The MLP further generates a score for each individual to quantify the functional significance of cells and genes. Across multiple datasets, scHILL outperforms existing methods in phenotype prediction and reveals individual-level immune cell heterogeneity in infectious disease, autoimmune disease, and cancer. scHILL provides a generalizable framework for interpreting individual-level scRNA-seq data, thereby facilitating the future realization of personalized medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.